Create account

Coverage dated November 17, 2022

FDA approves first treatment to delay onset of Type 1 diabetes

Headline from WMUR

In clinical trials, Tzield delayed progression to full-blown diabetes by a little over two years. But the benefits have lasted much longer in some of the study participants.

WMUR's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

9 articles, oldest first.

  1. WMUR

    FDA approves first treatment to delay onset of Type 1 diabetes (opens WMUR)

    Published

    WMUR's feed description

    In clinical trials, Tzield delayed progression to full-blown diabetes by a little over two years. But the benefits have lasted much longer in some of the study participants.

  2. Waterloo-Cedar Falls Courier

    FDA Approves First Drug to Delay Onset of Type 1 Diabetes (opens Waterloo-Cedar Falls Courier)

    Published

    Waterloo-Cedar Falls Courier's feed description

    FRIDAY, Nov. 18, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of type 1 diabetes (T1D).

  3. NBC News

    FDA approves 1st drug to delay the onset of Type 1 diabetes (opens NBC News)

    Published

    NBC News's feed description

    The injection is the first approved therapy for people who show early signs of the disease, though the drug's cost may limit access.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

FDA approves first treatment to delay onset of Type 1 diabetes | Since Then